sue.pngDr. Ostrand-Rosenberg has more than 40 years of experience as the PI of a laboratory studying the immune system’s response to cancer. Throughout this period, her lab’s long-term goal has been to manipulate an individual's immune response to reject cancer cells. In the 1990s, she and her team were instrumental in demonstrating that CD4+ T-helper lymphocytes facilitate T cell-mediated tumor rejection. 

Contact Us

Sue Ostrand-Rosenberg, PhD

Adjunct Professor of Pathology
Member, Huntsman Cancer Institute
University of Utah

Email Address: